We are thrilled to welcome Lauren Salisbury to the Nanopath team as #ResearchAssociate! She comes to us with a strong background in #compliance, #instrumentation, and a passion for developing better #diagnostics. Looking forward to creating new #solutions together. Welcome!

Happy Holidays from the Nanopath Team! Wishing you all the best in 2023 ❄️ nanopathdx.com

We'd like to extend a warm Nanopath welcome to Cassie Robinson, who joined us this week as #ResearchEngineer! Cassie joins the team with #engineering, #quality, and #clinical experience serving patients in #WomensHealth settings. We are so excited to have her onboard!

We are so happy to #welcome Matt Black, PhD, to the Nanopath Team as VP of #AssayDevelopment. Matt comes to us with 10 years of #experience leading assay development for the development of #invitro #diagnostics, most recently for #COVID19 and #flu. Welcome to the team, Matt!

We are thrilled to #welcome Uri Tayvah to the Nanopath team as Scientist! Uri comes to us with a #PhD in #chemistry - his dissertation focused on applications to #spectroscopy, modeling, and #dataanalysis. We are so happy to have him onboard!

Nanopath co-founders Amogha and Alison will be hosting the Northeast @_AACC chapter this Thursday for a seminar and tour at The Engine! We're looking forward to connecting with those in attendance. More details on the event: eventcreate.com/e/february-16-…

Happy #InternationalWomensDay! Nanopath was founded on the need to improve #WomensHealth - #empowering women everywhere to make #informed, timely decisions. We are proud to work each day with #women in mind.

After a break: the Empower 2023 Pitch Competition, at which six dynamic startups compete for $135,000 in cash prizes plus in-kind legal services: Nanopath, @Soliome1, Seia Bio, Hera Biotech, PolyGone Systems and AtomICs - plus an update from Sonavi Labs (5:30 pm ET 4/27)

Nanopath co-founders are presenting at 2 special events today! Amogha will be a pitch competition presenter at Princeton University Empower 2023. Alison will be representing Nanopath at MassMEDIC Medtech Impact during a panel on "where we are going?" in women's health diagnostics.

The Massachusetts Massachusetts pavilion is buzzing on Day 3 of #BIO2023. Come learn about the world’s #1 #LifeSciences ecosystem. Massachusetts Life Sciences Center MassBio Biotechnology Innovation Organization #WeAreTheLifeSciences

Nanopath welcomes Josselyn and Noah as Summer 2023 Interns! We are thrilled for them to join the team - looking forward to all we will accomplish together this summer!

We #welcome Monica Koubeck as Research Associate to Nanopath! She joins the team with experience in #assay development and optimizing for #pointofcare #diagnostics. We're excited about her shared passion for tackling #WomensHealth challenges, and to have her onboard!

#NSFSBIR startup Nanopath is empowering women and improving their health by using bioengineering and nanotechnology to detect human papillomavirus and urinary tract infections in minutes. bit.ly/3GHCoLj 📸: Nanopath

As we look forward to 2024, we’ve been reflecting on all the team has accomplished in 2023. • Our team completed over 700 experiments. • Our team grew to 12 full time employees. • Awarded $1M from the National Science Foundation. Excited to see what we will achieve in 2024!

Please join us in welcoming the newest additions to the Nanopath team; Fulya Ekiz Kanik and Henry Hwang! More detail about their exciting backgrounds on LinkedIn! linkedin.com/feed/update/ur…

On this International Women's Day, we're proud to be a part of a global movement that prioritizes and advances women's well-being through novel diagnostic solutions. Here's to progress, knowledge, and a healthier tomorrow for every woman.

Check out our Senior VP of Assay Development, Matthew Black, and Senior Scientist, Cameron Crawford, who represented Nanopath at Precision Med TRI-CON this week! linkedin.com/posts/nanopath…

Our cofounders, Amogha Tadimety & Alison Burklund, recently spent the day at the Medtech Impact Symposium. They found it incredibly enriching to connect with visionaries & industry leaders. As a company, we're so lucky to be part of such a supportive community. Thanks, MassMEDIC!

Dr. Amogha Tadimety, Co-Founder and CEO of portfolio company Nanopath, a trailblazing molecular diagnostics company focused on women’s health, recently sat down with AV CEO Mike Collins to discuss the company and her own entrepreneurial journey: av-funds.com/4bqOqpK

Help us welcome our two newest team members, George Roudebush and Minal Mardhani! Check out the full post on LinkedIn. linkedin.com/posts/nanopath…